Dr. Guda Dinneswara Reddy is a distinguished scientist and Director of Suviro Life Sciences, Hyderabad. With over two decades of experience in synthetic organic and heterocyclic chemistry, he has pioneered the development of novel molecules and catalysts spanning pharmaceutical, energy, and semiconductor applications. His research career, spanning senior positions in India and South Korea, reflects a rare blend of scientific depth and translational innovation.
His work encompasses new synthetic methodologies for heterocyclic compounds (triazoles, oxadiazoles, thiadiazoles, pyrazoles, and imidazoles) foundational to drug discovery and materials science, including a novel anti-allergy drug candidate currently under clinical trials. In artificial photosynthesis, he has designed mono- and di-nuclear metal-organic catalysts (Mn, Fe, Co, Ni, Ru, Ir, Re) for water oxidation, CO₂ reduction, and photochemical hydrogen production, published in journals such as Energy & Environmental Science. In the semiconductor domain, he has developed molybdenum- and tungsten-based ALD precursors, including substituted cyclopentadienyl and cyclohexadienyl derivatives, advancing thin-film deposition technologies for next-generation electronics.
Dr. Reddy holds 4 patents in ALD precursors and anti-allergy compounds, and has authored 40 research articles in leading scientific journals. His contributions have been recognized with several honours, including the IAAM Scientist Medal and the Yonsei Standing Proud Young Researcher Award.